Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Mur (Aberystwyth, United Kingdom). Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases. 375

Member's Comments

No comment yet.

Related content which might interest you: A combinational approach to optimize biomarkers efficacy in identifying patients with sarcoidosis and monitoring respiratory functional worsening Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012 A new statistical diagnostic tool for respiratory diseases Source: Virtual Congress 2020 – New and integrated tools for respiratory diagnosis and care Year: 2020 Application of ’omics technologies to biomarker discovery in inflammatory lung diseases Source: Eur Respir J 2013; 42: 802-825 Year: 2013 Applying clinical metagenomics for the detection and characterisation of respiratory infections Source: Eur Respir Monogr 2019; 83: 35-49 Year: 2019 Fine crackles quantitative value can help the diagnosis of interstitial lung diseases – Clinical utility of the innovative analyzing system of respiratory sounds Source: International Congress 2019 – Innovations in primary care assessment and management Year: 2019 Sputum induction for assessment of biomarkers in early development of new drugs for respiratory disease in a proof of concept setting Source: International Congress 2016 – Airway biomarkers Year: 2016 The omics approach to defining endotypes and personalising treatment pathways in asthma Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease Year: 2016 A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes Source: Eur Respir J, 59 (1) 2102603; 10.1183/13993003.02603-2021 Year: 2022 Molecular epidemiology of adverse respiratory effects: A high-throughput screening method to detect biomarkers of genotoxic exposure Source: Annual Congress 2010 - Causal factors and mechanisms of outdoor air pollution and nanoparticulates Year: 2010 Are FENO indices useful diagnostic tools in suspected asthma? Experience of a routine lung function laboratory Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 Integrating systems biology in respiratory diseases Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research Year: 2016 High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications Source: Eur Respir J 2009; 33: 489-506 Year: 2009 New approaches to tuberculosis diagnosis through the study of metabolomic profile in urine Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 Overview and history of different ways of assessing and monitoring inflammatory airway diseases Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease Year: 2017 Monitoring asthma – state-of-the-art physiological, imaging, and biomarker assessments Source: International Congress 2015 – PG2 Asthma and COPD Year: 2015 Applying new respiratory function technologies to the elderly and the potential of future lung regeneration Source: Virtual Congress 2020 – Lung health and respiratory function at all ages Year: 2020